These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16820342)

  • 21. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension.
    Karaman M; Balta S; Seyit Ahmet AY; Cakar M; Naharci I; Demirkol S; Celik T; Arslan Z; Kurt O; Kocak N; Sarlak H; Demirbas S; Bulucu F; Bozoglu E
    Clin Exp Hypertens; 2013; 35(7):516-22. PubMed ID: 23289969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
    Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
    Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan.
    Konishi Y; Morikawa T; Okada N; Maeda I; Kitabayashi C; Yoshioka K; Okumura M; Nishiyama A; Ueda M; Takai S; Miyazaki M; Imanishi M
    Hypertens Res; 2008 Aug; 31(8):1517-24. PubMed ID: 18971525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
    Albayrak S; Ordu S; Ozhan H; Yazici M; Aydin M; Alemdar R; Kaya A
    Blood Press; 2009; 18(4):187-91. PubMed ID: 19521888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dilation of the brachial artery in response to sublingual nitroglycerin can predict the antihypertensive effects of valsartan: a study using novel high-frequency high-frame-rate ultrasound imaging].
    Inoue M; Fujii S; Taisei M; Furumoto T; Kaga S; Komatsu H; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Tsutsui H
    J Cardiol; 2006 Jan; 47(1):9-14. PubMed ID: 16475468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 30. Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study).
    Macdonald K; Brié H; Vancayzeele S; Lee C; Bowles J; Piotrowski K; Hermans C; Abraham I
    Arch Cardiovasc Dis; 2013 Mar; 106(3):124-34. PubMed ID: 23582674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension.
    Hashimoto J; Ito S
    Hypertension; 2011 Nov; 58(5):839-46. PubMed ID: 21968753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
    Ridker PM; Danielson E; Rifai N; Glynn RJ;
    Hypertension; 2006 Jul; 48(1):73-9. PubMed ID: 16714425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study.
    Spanos G; Kalaitzidis R; Karasavvidou D; Pappas K; Siamopoulos KC
    J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):315-21. PubMed ID: 23132848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Solomon SD; Janardhanan R; Verma A; Bourgoun M; Daley WL; Purkayastha D; Lacourcière Y; Hippler SE; Fields H; Naqvi TZ; Mulvagh SL; Arnold JM; Thomas JD; Zile MR; Aurigemma GP;
    Lancet; 2007 Jun; 369(9579):2079-87. PubMed ID: 17586303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis.
    Suzuki H; Okada K; Abe M; Maruyama N; Yoshida Y; Baba S; Takashima H; Soma M
    Clin Exp Nephrol; 2013 Jun; 17(3):386-95. PubMed ID: 23135868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients.
    Unlu M; Karaman M; Ay SA; Balta S; Cakar M; Demirkol S; Celik T; Arslan E; Demirbas S; Turker T; Yaman H; Bulucu F; Sağlam K
    Clin Exp Hypertens; 2013; 35(6):418-23. PubMed ID: 23148500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the renoprotective effects of benidipine and valsartan in primary hypertensive patients with proteinuria.
    Peng T; Hu Z; Xia Q; Jiang B; Li X; Yang X
    Arzneimittelforschung; 2009; 59(12):647-50. PubMed ID: 20108651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease.
    Mochizuki S; Shimizu M; Taniguchi I; Kanae K; Yoshida S; Tajima N; Dahlöf B;
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):305-9. PubMed ID: 15367828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.